Strona główna・Stock List・STRATEC Biomedical AG

STRATEC Biomedical AG

Closed

23.35 0.21

Buy Sell

Overview

Share price change

24h

Current

Min

22.95

Max

23.45

Key metrics
By Trading Economics
Income	5.9M 4.2M
Sales	5.7M 59M
EPS	0.342
Dividend yield	2.54
Profit margin	7.041
Employees	1,383
EBITDA	4.4M 8.5M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+23.4% upside

Dividends
By Acuity
Dividend yield Sector Avg	2.54% 3.34%
Next Earnings	12 lis 2026

Market Stats
By TradingEconomics
Market Cap	27M 274M
Previous open	23.14
Previous close	23.35

STRATEC Biomedical AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 paź 2026, 23:51 UTC

Building Permits MoM Final Data for September 2026 Expected to Decline by -0.2% Amid Cautious Market Sentiment Ahead of Release on October 27.

24 paź 2026, 23:51 UTC

Australia's Q3 2026 Producer Price Inflation Expected to Rise Slightly Amid Mixed Economic Sentiment and Rising Oil Prices.

24 paź 2026, 23:42 UTC

PCE Price Index MoM for September 2026 set to release on October 29, with a forecasted increase of 0.5%, amid cautious market sentiment and rising inflation concerns influenced by geopolitical tensions and mixed economic signals.

24 paź 2026, 23:42 UTC

U.S. Q3 2026 GDP Growth Rate Release on October 29 Expected at 3.2% Amid Mixed Market Sentiment and Inflation Concerns

24 paź 2026, 23:42 UTC

Core PCE Price Index for September 2026 set to release on October 29, with a forecasted increase of 0.3%, amid cautious investor sentiment ahead of key economic indicators and FOMC meetings.

24 paź 2026, 23:42 UTC

Upcoming Q3 2026 GDP Price Index Release on October 29 Expected to Signal Inflation Trends Amid Rising Oil Prices and Market Volatility.

24 paź 2026, 23:42 UTC

US Personal Income Expected to Rise 0.3% in September Amid Cautious Economic Sentiment and Inflation Concerns

24 paź 2026, 23:42 UTC

Upcoming PCE Price Index Release on October 29, 2026, Sparks Market Caution Amid Inflation Concerns and Potential Rate Hikes.

24 paź 2026, 23:42 UTC

Personal Spending MoM data for September 2026 set to release on October 29, with a forecasted increase of 0.3%, amid cautious optimism and rising consumer cost concerns.

24 paź 2026, 23:31 UTC

Brazil's Unemployment Rate for September 2026 Set to Release on October 30, with Analysts Expecting Stability at 5.3% Amid Positive Economic Trends.

24 paź 2026, 23:31 UTC

Mexico's Q3 2026 GDP Growth Rate Release on October 30 Faces Pressure from Geopolitical Tensions and Inflationary Concerns.

24 paź 2026, 23:31 UTC

Mexico's GDP Growth Rate Expected to Show Continued Recovery Amid Global Economic Uncertainty Ahead of October 30 Release.

24 paź 2026, 23:31 UTC

S&P/Case-Shiller Home Price Index Set for October 27 Release, Anticipating 2.6% Growth Amid Economic Uncertainties and Fed Rate Hike Concerns.

24 paź 2026, 23:31 UTC

South Africa's Balance of Trade data set for October 30, showing potential continued export strength amid cautious optimism.

24 paź 2026, 23:31 UTC

Brazil's Central Bank to announce interest rate decisions on October 26, with cautious optimism reflected in rising $EWZ ETF amid global inflation concerns.

24 paź 2026, 23:21 UTC

Upcoming U.S. Retail Inventories Ex Autos Data Release on October 28, 2026 Expected to Impact Consumer Spending and Economic Outlook Amid Inflation Concerns.

24 paź 2026, 23:21 UTC

Wholesale Inventories Data Release on October 28 Expected to Show 0.4% Growth Amid Cautious Market Sentiment and Rising Oil Prices.

24 paź 2026, 23:21 UTC

U.S. Goods Trade Balance for September 2026 Expected to Show $128.7 Billion Deficit Amid Tariff Policy Changes and Geopolitical Tensions

24 paź 2026, 23:21 UTC

Macro News

News

Bitcoin declines amid ongoing geopolitical tensions and El Salvador's new 0% tax rate on gains, requiring only a 90-day residency for individuals.

24 paź 2026, 23:11 UTC

Australia's RBA Trimmed Mean CPI release on October 28 sparks cautious market sentiment amid declining stocks and rising inflation concerns.

24 paź 2026, 23:11 UTC

Japan's Retail Sales Expected to Rise 3.3% YoY Amid Inflation and Market Volatility Concerns

24 paź 2026, 23:11 UTC

Australia's Inflation Rate Expected to Rise to 4.2% in September, Influencing Global Economic Sentiment and Interest Rate Speculations

24 paź 2026, 23:11 UTC

Japan's Industrial Production MoM data for September 2026 is expected to show a modest recovery of +1.3% after two months of contraction, amid mixed economic signals and cautious investor sentiment.

24 paź 2026, 23:01 UTC

US Durable Goods Orders Ex Transportation Expected to Rise 0.006% Amid Cautious Market Sentiment Ahead of Fed Policy Meeting

24 paź 2026, 23:01 UTC

Durable Goods Orders for September 2026 Expected to Rise by 0.6% Amid Cautious Market Sentiment and Key Economic Events Ahead

24 paź 2026, 23:01 UTC

Ethereum is declining, continuing a downward trend since Friday's close amid challenging broader market conditions and geopolitical tensions, positioned below its 20-day moving average.

24 paź 2026, 22:51 UTC

Japan's September 2026 unemployment rate forecast at 2.5% sparks cautious market sentiment amid economic volatility and rising inflation pressures.

24 paź 2026, 22:41 UTC

MBA 30-Year Mortgage Rate Release on October 28 Expected Amid Cautious Optimism Following Recent Decline to 7.41%

24 paź 2026, 22:41 UTC

Cautious Market Sentiment Ahead of Chicago Fed National Activity Index Release Amid Rising Oil Prices and Volatile Equity Markets

24 paź 2026, 22:31 UTC

Mexico's Balance of Trade Report on October 27 Sparks Caution Amid Mixed Expectations and U.S. Tariff Changes.

Peer Comparison

Price change

STRATEC Biomedical AG Forecast

Price Target

By TipRanks

23.4% upside

12 Months Forecast

Average 29 EUR 23.4%

High 37 EUR

Low 21 EUR

Based on 2 Wall Street analysts offering 12 month price targets forSTRATEC Biomedical AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to STRATEC Biomedical AG - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.